ArcticZymes Technologies ASA (LTS:0DRV) Total Receivables: kr19.6 Mil (As of Mar. 2026)


LTS:0DRV ArcticZymes Technologies ASA LTS:0DRV
77 GF Score
Price kr20.90
GF Value kr23.89
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is ArcticZymes Technologies ASA Total Receivables?

ArcticZymes Technologies ASA LTS:0DRV 77 Total Receivables is kr19.6 Mil as of Mar. 2026. GuruFocus rates LTS:0DRV with a GF Score™ of 77/100 and a GF Value™ of kr23.89 (Modestly Undervalued). The stock has 1 warning sign investors should review.

ArcticZymes Technologies ASA's Total Receivables for the quarter that ended in Mar. 2026 was kr19.6 Mil.

ArcticZymes Technologies ASA Total Receivables Related Terms

ArcticZymes Technologies ASA Total Receivables Historical Data

* Premium members only.

The historical data trend for ArcticZymes Technologies ASA's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ArcticZymes Technologies ASA Total Receivables Chart

ArcticZymes Technologies ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.27 12.41 13.78 20.53 21.88

ArcticZymes Technologies ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.47 18.07 13.34 21.88 19.60
LTS:0DRV
77GF Score
ArcticZymes Technologies ASA LTS:0DRV
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ArcticZymes Technologies ASA Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of kr19.6 Mil mean?
ArcticZymes Technologies ASA (LTS:0DRV) has a Total Receivables of kr19.6 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on ArcticZymes Technologies ASA and its competitors.
Is ArcticZymes Technologies ASA's Total Receivables too high?
ArcticZymes Technologies ASA's current Total Receivables is kr19.6 Mil. Overall, ArcticZymes Technologies ASA has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ArcticZymes Technologies ASA's Total Receivables compare to VRTX and REGN?
ArcticZymes Technologies ASA's Total Receivables of kr19.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on ArcticZymes Technologies ASA and its competitors. ArcticZymes Technologies ASA's current Total Receivables is kr19.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ArcticZymes Technologies ASA stock overvalued right now?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA (LTS:0DRV) is currently considered Modestly Undervalued. The stock's GF Value™ is kr23.89, compared to a current price of kr20.90 — trading 12.5% below its estimated fair value. The current Total Receivables is kr19.6 Mil. ArcticZymes Technologies ASA's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For ArcticZymes Technologies ASA (LTS:0DRV), the current Total Receivables is kr19.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ArcticZymes Technologies ASA (LTS:0DRV) Overvalued in 2026?

Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued. The current stock price of kr20.90 is trading 12.5% below its estimated GF Value™ of kr23.89. GuruFocus considers ArcticZymes Technologies ASA to be Modestly Undervalued.

Key valuation signals for LTS:0DRV:

  • Total Receivables: kr19.6 Mil
  • GF Value™: kr23.89 vs. price of kr20.90 (12.5% below fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the LTS:0DRV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ArcticZymes Technologies ASA Business Description

Other Exchanges BIOTECO:SwedenAZT:Norway
Address Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
77GF Score

Get the complete analysis for LTS:0DRV

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr20.90
Price
kr23.89
GF Value